Ushering in a new era of cell culture production with new capacity and digitalization.

When scaling, you can make better use of existing chromatography columns while avoiding overcapacity. Try this alternative approach to achieve a constant residence time.

Introducing KUBio BSL-2 facility to meet the industry's growing production demands for viral vector therapies.